Cresco Labs Announces Upcoming Conference Participation
September 06 2023 - 6:30AM
Business Wire
Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or
“Company”), the industry leader in branded cannabis products with a
portfolio of America’s most popular brands and the operator of
Sunnyside dispensaries, today announced planned participation in
upcoming conferences in September.
ATB 2023 Life Sciences Institutional Investor Conference,
September 20, 2023, New York City: Chief Executive Officer
Charles Bachtell will participate in a fireside chat and Management
will participate in one-on-one meetings.
Benzinga Cannabis Capital Conference, September 27-28, 2023,
Chicago: Chief Executive Officer Charles Bachtell will
participate in a fireside chat and Management will participate in
one-on-one and small group meetings.
AGP Annual Virtual Cannabis Conference, October 4, 2023:
Chief Executive Officer Charles Bachtell will participate in a
panel titled “Balancing Near-Term Verticalization & Long-Term
CPG Aspirations” and Management will participate in one-on-one
meetings.
About Cresco Labs Inc.
Cresco Labs’ mission is to normalize and professionalize the
cannabis industry through a CPG approach to building national
brands and a customer-focused retail experience, while acting as a
steward for the industry on legislative and regulatory-focused
initiatives. As a leader in cultivation, production and branded
product distribution, the Company is leveraging its scale and
agility to grow its portfolio of brands that include Cresco, High
Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and
Remedi, on a national level. The Company also operates highly
productive dispensaries nationally under the Sunnyside brand that
focus on building patient and consumer trust and delivering ongoing
education and convenience in a wonderfully traditional retail
experience. Through year-round policy, community outreach and SEED
initiative efforts, Cresco Labs embraces the responsibility to
support communities through authentic engagement, economic
opportunity, investment, workforce development and legislative
initiatives designed to create the most responsible, respectable
and robust cannabis industry possible. Learn more about Cresco
Labs’ journey by visiting www.crescolabs.com or following the
Company on Facebook, X or LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230906781962/en/
Media: Jason Erkes, Cresco Labs Chief Communications Officer
press@crescolabs.com Investors: Megan Kulick, Cresco Labs Senior
Vice President, Investor Relations investors@crescolabs.com For
general Cresco Labs inquiries: 312-929-0993 info@crescolabs.com
Cresco Labs (TG:6CQ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cresco Labs (TG:6CQ)
Historical Stock Chart
From Sep 2023 to Sep 2024